Balance sheet of Anthem Biosciences is strong.
It shouldn't have solvency or liquidity issues.

The debt of Anthem Biosciences is decreasing.
Latest debt of Anthem Biosciences is -₹525 Crs as of Mar-25.
This is less than Mar-24 when it was -₹136.19 Crs.

The profit is oscillating.
The profit of Anthem Biosciences is ₹218 Crs for TTM, ₹451 Crs for Mar 2025 and ₹367 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Anthem Biosciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery